Internal Medicine, Medical Oncology · Duarte, CA
NPI
1841599107
Since 2011
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
1500 Duarte Rd
Duarte, CA, 91010
Phone (626) 359-8111
Groups this clinician bills Medicare through
Medicare paid, 2024
$96K
4,854 services
Medicare patients, 2024
30
Average age 66
Drug cost, 2024
$7.8M
1,361 prescriptions
Company payments, 2025
$27.85
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anh Pham was code J7030 (infusion, normal saline solution , 1000 cc), 17 times for 12 patients. In total Anh Pham billed 4,854 services in 48 codes, and Medicare paid $96K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J7030 Infusion, normal saline solution , 1000 cc | Office | 17 | 12 | $2.07 | $35.15 |
By year: 2022 $7,679 for 701 services; 2023 $48K for 2,353 services; 2024 $96K for 4,854 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anh Pham prescribed most often to Medicare patients was Anastrozole, with 182 prescriptions and refills. In total Anh Pham wrote 1,361 Medicare prescriptions that cost $7.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 182 | 545 | 76 | $5,105 |
| Tagrisso Osimertinib Mesylate | 118 | 118 | 16 | $2.0M |
| Abiraterone Acetate Generic | 117 | 131 | 22 | $45K |
| Prednisone Generic | 108 | 146 | 25 | $878 |
| Hydroxyurea Generic | 68 | 153 | 17 | $2,154 |
| Dexamethasone Generic | 65 | 87 | 25 | $837 |
| Prochlorperazine Maleate Generic | 65 | 65 | 33 | $828 |
| Ondansetron Odt Ondansetron | 62 | 62 | 38 | $672 |
| Lenalidomide Generic | 44 | 44 | 14 | $561K |
| Tabrecta Capmatinib Hydrochloride | 37 | 37 | Under 11 | $831K |
| Pomalyst Pomalidomide | 34 | 34 | Under 11 | $835K |
| Retevmo Selpercatinib | 31 | 31 | Under 11 | $626K |
| Acyclovir Generic | 28 | 42 | Under 11 | $474 |
| Brukinsa Zanubrutinib | 24 | 24 | Under 11 | $315K |
| Exemestane Generic | 21 | 61 | Under 11 | $1,657 |
Brand drugs: 440 claims; generic drugs: 921 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anh Pham $27.85 ($27.85 in general payments such as food, travel and fees) from 1 company. The largest payer was Novo Nordisk Inc with $27.85.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 1 | $27.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.